Building a Framework for Measuring RWE’s Strategic Value Beyond Activity Metrics
- Discover why traditional project-level metrics (e.g. number of studies, publications) fall short in capturing the true impact of RWE functions
- Benchmark emerging approaches to evaluate how evidence planning contributes to launch readiness, market access, and clinical decision-making
- Learn practical strategies to capture long-term impact from shaping prescriber behaviour to influencing HTA/payer decisions, despite gaps in unbiased, representative datasets